Mitsubishi Tanabe Pharma America to Present Latest Parkinson's Disease Research at the 10th Congress of the European Academy of Neurology [Yahoo! Finance]
MITSUBISHI CH GRP U/ADR (MTLHY)
NASDAQ:AMEX Investor Relations:
mitsubishichem-hd.co.jp/english/ir
Company Research
Source: Yahoo! Finance
ND0612 in Parkinson's disease (PD) will be shared at the 10 th Congress of the European Academy of Neurology (EAN), being held in Helsinki, Finland June 29 – July 2 "We are excited to be at EAN this year to showcase our ongoing research and engage with the scientific community," said Gustavo A. Suarez Zambrano , M.D., Vice President of Medical Affairs, MTPA. "These findings highlight our dedication to advancing the understanding of investigational ND0612 and our commitment to recognizing the unmet needs of people living with Parkinson's disease." Presentation Details: Presentations include findings from subgroup analyses of the pivotal Phase 3 multi-center, randomized, double-blind double-dummy BouNDless trial ( NCT04006210 ) evaluating the efficacy, safety and tolerability of investigational ND0612 in people with PD experiencing motor fluctuations, as well as a secondary analysis from a Phase 2 study ( NCT02577523 ), which evaluated the onset of efficacy with ND0612 utilizing pat
Show less
Read more
Impact Snapshot
Event Time:
MTLHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MTLHY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MTLHY alerts
High impacting MITSUBISHI CH GRP U/ADR news events
Weekly update
A roundup of the hottest topics
MTLHY
News
- Global Rare Gas Market to reach a valuation of US$ 6.5 billion by 2034 | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Lithium and Lithium Ion Battery Electrolyte Market to Advance at a 12.2% CAGR by 2034 as Electric Vehicle Sales are Hitting the Roof | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Empty Capsules Market: USD 4.2B by 2029, 6.3% CAGR, Driven by Nutraceuticals & Pharmaceuticals | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS [Yahoo! Finance]Yahoo! Finance